ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single-target MET TKIs Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-28D17889
Home | Market Reports | Health| Health Conditions| Cancer
Global Single target MET TKIs Market Research Report 2024
BUY CHAPTERS

Global Single-target MET TKIs Market Research Report 2026

Code: QYRE-Auto-28D17889
Report
2026-02-13
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
WuXi STA
Shanghai Hutchison Pharmaceuticals
Haihe Biopharma
CSPC Pharmaceutical
Asymchem
Avistone Pharmaceuticals Biotechnology

Single-target MET TKIs Market

The global Single-target MET TKIs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Single-target MET TKIs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Single-target MET tyrosine kinase inhibitors (TKIs) are drugs specifically designed to block the activity of the MET receptor tyrosine kinase alone, focusing on disrupting the MET signaling pathway that promotes cancer cell growth, survival, and metastasis.
The North American market for Single-target MET TKIs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Single-target MET TKIs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Single-target MET TKIs include Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Single-target MET TKIs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Single-target MET TKIs. The Single-target MET TKIs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Single-target MET TKIs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Single-target MET TKIs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Single-target MET TKIs Market Report

Report Metric Details
Report Name Single-target MET TKIs Market
Segment by Type
  • Capmatinib
  • Tepotinib
  • Savolitinib
  • Glumetinib
  • Vebreltinib
  • Other
by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Single-target MET TKIs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Single-target MET TKIs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Single-target MET TKIs Market report?

Ans: The main players in the Single-target MET TKIs Market are Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem

What are the Application segmentation covered in the Single-target MET TKIs Market report?

Ans: The Applications covered in the Single-target MET TKIs Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Single-target MET TKIs Market report?

Ans: The Types covered in the Single-target MET TKIs Market report are Capmatinib, Tepotinib, Savolitinib, Glumetinib, Vebreltinib, Other

1 Single-target MET TKIs Market Overview
1.1 Product Definition
1.2 Single-target MET TKIs by Type
1.2.1 Global Single-target MET TKIs Market Value by Type: 2025 vs 2032
1.2.2 Capmatinib
1.2.3 Tepotinib
1.2.4 Savolitinib
1.2.5 Glumetinib
1.2.6 Vebreltinib
1.2.7 Other
1.3 Single-target MET TKIs by Application
1.3.1 Global Single-target MET TKIs Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Single-target MET TKIs Market Size Estimates and Forecasts
1.4.1 Global Single-target MET TKIs Revenue 2021–2032
1.4.2 Global Single-target MET TKIs Sales 2021–2032
1.4.3 Global Single-target MET TKIs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Single-target MET TKIs Market Competition by Manufacturers
2.1 Global Single-target MET TKIs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Single-target MET TKIs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Single-target MET TKIs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Single-target MET TKIs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Single-target MET TKIs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Single-target MET TKIs, Product Types and Applications
2.7 Global Key Manufacturers of Single-target MET TKIs, Date of Entry into the Industry
2.8 Global Single-target MET TKIs Market Competitive Situation and Trends
2.8.1 Global Single-target MET TKIs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Single-target MET TKIs Players Market Share by Revenue
2.8.3 Global Single-target MET TKIs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Single-target MET TKIs Market Scenario by Region
3.1 Global Single-target MET TKIs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Single-target MET TKIs Sales by Region: 2021–2032
3.2.1 Global Single-target MET TKIs Sales by Region: 2021–2026
3.2.2 Global Single-target MET TKIs Sales by Region: 2027–2032
3.3 Global Single-target MET TKIs Revenue by Region: 2021–2032
3.3.1 Global Single-target MET TKIs Revenue by Region: 2021–2026
3.3.2 Global Single-target MET TKIs Revenue by Region: 2027–2032
3.4 North America Single-target MET TKIs Market Facts & Figures by Country
3.4.1 North America Single-target MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Single-target MET TKIs Sales by Country (2021–2032)
3.4.3 North America Single-target MET TKIs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Single-target MET TKIs Market Facts & Figures by Country
3.5.1 Europe Single-target MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Single-target MET TKIs Sales by Country (2021–2032)
3.5.3 Europe Single-target MET TKIs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single-target MET TKIs Market Facts & Figures by Region
3.6.1 Asia Pacific Single-target MET TKIs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Single-target MET TKIs Sales by Region (2021–2032)
3.6.3 Asia Pacific Single-target MET TKIs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Single-target MET TKIs Market Facts & Figures by Country
3.7.1 Latin America Single-target MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Single-target MET TKIs Sales by Country (2021–2032)
3.7.3 Latin America Single-target MET TKIs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Single-target MET TKIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Single-target MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Single-target MET TKIs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Single-target MET TKIs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Single-target MET TKIs Sales by Type (2021–2032)
4.1.1 Global Single-target MET TKIs Sales by Type (2021–2026)
4.1.2 Global Single-target MET TKIs Sales by Type (2027–2032)
4.1.3 Global Single-target MET TKIs Sales Market Share by Type (2021–2032)
4.2 Global Single-target MET TKIs Revenue by Type (2021–2032)
4.2.1 Global Single-target MET TKIs Revenue by Type (2021–2026)
4.2.2 Global Single-target MET TKIs Revenue by Type (2027–2032)
4.2.3 Global Single-target MET TKIs Revenue Market Share by Type (2021–2032)
4.3 Global Single-target MET TKIs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Single-target MET TKIs Sales by Application (2021–2032)
5.1.1 Global Single-target MET TKIs Sales by Application (2021–2026)
5.1.2 Global Single-target MET TKIs Sales by Application (2027–2032)
5.1.3 Global Single-target MET TKIs Sales Market Share by Application (2021–2032)
5.2 Global Single-target MET TKIs Revenue by Application (2021–2032)
5.2.1 Global Single-target MET TKIs Revenue by Application (2021–2026)
5.2.2 Global Single-target MET TKIs Revenue by Application (2027–2032)
5.2.3 Global Single-target MET TKIs Revenue Market Share by Application (2021–2032)
5.3 Global Single-target MET TKIs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis Single-target MET TKIs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Single-target MET TKIs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 WuXi STA
6.3.1 WuXi STA Company Information
6.3.2 WuXi STA Description and Business Overview
6.3.3 WuXi STA Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 WuXi STA Single-target MET TKIs Product Portfolio
6.3.5 WuXi STA Recent Developments/Updates
6.4 Shanghai Hutchison Pharmaceuticals
6.4.1 Shanghai Hutchison Pharmaceuticals Company Information
6.4.2 Shanghai Hutchison Pharmaceuticals Description and Business Overview
6.4.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio
6.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
6.5 Haihe Biopharma
6.5.1 Haihe Biopharma Company Information
6.5.2 Haihe Biopharma Description and Business Overview
6.5.3 Haihe Biopharma Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Haihe Biopharma Single-target MET TKIs Product Portfolio
6.5.5 Haihe Biopharma Recent Developments/Updates
6.6 CSPC Pharmaceutical
6.6.1 CSPC Pharmaceutical Company Information
6.6.2 CSPC Pharmaceutical Description and Business Overview
6.6.3 CSPC Pharmaceutical Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 CSPC Pharmaceutical Single-target MET TKIs Product Portfolio
6.6.5 CSPC Pharmaceutical Recent Developments/Updates
6.7 Avistone Pharmaceuticals Biotechnology
6.7.1 Avistone Pharmaceuticals Biotechnology Company Information
6.7.2 Avistone Pharmaceuticals Biotechnology Description and Business Overview
6.7.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio
6.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
6.8 Asymchem
6.8.1 Asymchem Company Information
6.8.2 Asymchem Description and Business Overview
6.8.3 Asymchem Single-target MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Asymchem Single-target MET TKIs Product Portfolio
6.8.5 Asymchem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single-target MET TKIs Industry Chain Analysis
7.2 Single-target MET TKIs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single-target MET TKIs Production Mode & Process Analysis
7.4 Single-target MET TKIs Sales and Marketing
7.4.1 Single-target MET TKIs Sales Channels
7.4.2 Single-target MET TKIs Distributors
7.5 Single-target MET TKIs Customer Analysis
8 Single-target MET TKIs Market Dynamics
8.1 Single-target MET TKIs Industry Trends
8.2 Single-target MET TKIs Market Drivers
8.3 Single-target MET TKIs Market Challenges
8.4 Single-target MET TKIs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
WuXi STA
Shanghai Hutchison Pharmaceuticals
Haihe Biopharma
CSPC Pharmaceutical
Asymchem
Avistone Pharmaceuticals Biotechnology
List of Tables
 Table 1. Global Single-target MET TKIs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Single-target MET TKIs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Single-target MET TKIs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Single-target MET TKIs Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Single-target MET TKIs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Single-target MET TKIs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Single-target MET TKIs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Single-target MET TKIs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Single-target MET TKIs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Single-target MET TKIs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Single-target MET TKIs, Product Types and Applications
 Table 12. Global Key Manufacturers of Single-target MET TKIs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Single-target MET TKIs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Single-target MET TKIs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Single-target MET TKIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Single-target MET TKIs Sales by Region (K Units), 2021–2026
 Table 18. Global Single-target MET TKIs Sales Market Share by Region (2021–2026)
 Table 19. Global Single-target MET TKIs Sales by Region (K Units), 2027–2032
 Table 20. Global Single-target MET TKIs Sales Market Share by Region (2027–2032)
 Table 21. Global Single-target MET TKIs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Single-target MET TKIs Revenue Market Share by Region (2021–2026)
 Table 23. Global Single-target MET TKIs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Single-target MET TKIs Revenue Market Share by Region (2027–2032)
 Table 25. North America Single-target MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Single-target MET TKIs Sales by Country (K Units), 2021–2026
 Table 27. North America Single-target MET TKIs Sales by Country (K Units), 2027–2032
 Table 28. North America Single-target MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Single-target MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Single-target MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Single-target MET TKIs Sales by Country (K Units), 2021–2026
 Table 32. Europe Single-target MET TKIs Sales by Country (K Units), 2027–2032
 Table 33. Europe Single-target MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Single-target MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Single-target MET TKIs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Single-target MET TKIs Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Single-target MET TKIs Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Single-target MET TKIs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Single-target MET TKIs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Single-target MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Single-target MET TKIs Sales by Country (K Units), 2021–2026
 Table 42. Latin America Single-target MET TKIs Sales by Country (K Units), 2027–2032
 Table 43. Latin America Single-target MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Single-target MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Single-target MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Single-target MET TKIs Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Single-target MET TKIs Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Single-target MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Single-target MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Single-target MET TKIs Sales (K Units) by Type (2021–2026)
 Table 51. Global Single-target MET TKIs Sales (K Units) by Type (2027–2032)
 Table 52. Global Single-target MET TKIs Sales Market Share by Type (2021–2026)
 Table 53. Global Single-target MET TKIs Sales Market Share by Type (2027–2032)
 Table 54. Global Single-target MET TKIs Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Single-target MET TKIs Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Single-target MET TKIs Revenue Market Share by Type (2021–2026)
 Table 57. Global Single-target MET TKIs Revenue Market Share by Type (2027–2032)
 Table 58. Global Single-target MET TKIs Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Single-target MET TKIs Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Single-target MET TKIs Sales (K Units) by Application (2021–2026)
 Table 61. Global Single-target MET TKIs Sales (K Units) by Application (2027–2032)
 Table 62. Global Single-target MET TKIs Sales Market Share by Application (2021–2026)
 Table 63. Global Single-target MET TKIs Sales Market Share by Application (2027–2032)
 Table 64. Global Single-target MET TKIs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Single-target MET TKIs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Single-target MET TKIs Revenue Market Share by Application (2021–2026)
 Table 67. Global Single-target MET TKIs Revenue Market Share by Application (2027–2032)
 Table 68. Global Single-target MET TKIs Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Single-target MET TKIs Price (US$/Unit) by Application (2027–2032)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Novartis Single-target MET TKIs Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Single-target MET TKIs Product
 Table 79. Merck Recent Developments/Updates
 Table 80. WuXi STA Company Information
 Table 81. WuXi STA Description and Business Overview
 Table 82. WuXi STA Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. WuXi STA Single-target MET TKIs Product
 Table 84. WuXi STA Recent Developments/Updates
 Table 85. Shanghai Hutchison Pharmaceuticals Company Information
 Table 86. Shanghai Hutchison Pharmaceuticals Description and Business Overview
 Table 87. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product
 Table 89. Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
 Table 90. Haihe Biopharma Company Information
 Table 91. Haihe Biopharma Description and Business Overview
 Table 92. Haihe Biopharma Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Haihe Biopharma Single-target MET TKIs Product
 Table 94. Haihe Biopharma Recent Developments/Updates
 Table 95. CSPC Pharmaceutical Company Information
 Table 96. CSPC Pharmaceutical Description and Business Overview
 Table 97. CSPC Pharmaceutical Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. CSPC Pharmaceutical Single-target MET TKIs Product
 Table 99. CSPC Pharmaceutical Recent Developments/Updates
 Table 100. Avistone Pharmaceuticals Biotechnology Company Information
 Table 101. Avistone Pharmaceuticals Biotechnology Description and Business Overview
 Table 102. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product
 Table 104. Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
 Table 105. Asymchem Company Information
 Table 106. Asymchem Description and Business Overview
 Table 107. Asymchem Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Asymchem Single-target MET TKIs Product
 Table 109. Asymchem Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Single-target MET TKIs Distributors List
 Table 113. Single-target MET TKIs Customers List
 Table 114. Single-target MET TKIs Market Trends
 Table 115. Single-target MET TKIs Market Drivers
 Table 116. Single-target MET TKIs Market Challenges
 Table 117. Single-target MET TKIs Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Single-target MET TKIs
 Figure 2. Global Single-target MET TKIs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Single-target MET TKIs Market Share by Type: 2025 & 2032
 Figure 4. Capmatinib Product Picture
 Figure 5. Tepotinib Product Picture
 Figure 6. Savolitinib Product Picture
 Figure 7. Glumetinib Product Picture
 Figure 8. Vebreltinib Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Single-target MET TKIs Market Value by Application (US$ Million), 2021–2032
 Figure 11. Global Single-target MET TKIs Market Share by Application: 2025 & 2032
 Figure 12. Hospital and Clinic
 Figure 13. Retail Pharmacies
 Figure 14. Other
 Figure 15. Global Single-target MET TKIs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Single-target MET TKIs Market Size (US$ Million), 2021–2032
 Figure 17. Global Single-target MET TKIs Sales (K Units), 2021–2032
 Figure 18. Global Single-target MET TKIs Average Price (US$/Unit), 2021–2032
 Figure 19. Single-target MET TKIs Report Years Considered
 Figure 20. Single-target MET TKIs Sales Share by Manufacturers in 2025
 Figure 21. Global Single-target MET TKIs Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Single-target MET TKIs Players: Market Share by Revenue in Single-target MET TKIs in 2025
 Figure 23. Single-target MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Single-target MET TKIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Single-target MET TKIs Sales Market Share by Country (2021–2032)
 Figure 26. North America Single-target MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 27. United States Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Single-target MET TKIs Sales Market Share by Country (2021–2032)
 Figure 30. Europe Single-target MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Single-target MET TKIs Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Single-target MET TKIs Revenue Market Share by Region (2021–2032)
 Figure 38. China Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. China Taiwan Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Southeast Asia Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Single-target MET TKIs Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Single-target MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Colombia Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Single-target MET TKIs Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Single-target MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Single-target MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Single-target MET TKIs by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Single-target MET TKIs by Type (2021–2032)
 Figure 58. Global Single-target MET TKIs Price (US$/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Single-target MET TKIs by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Single-target MET TKIs by Application (2021–2032)
 Figure 61. Global Single-target MET TKIs Price (US$/Unit) by Application (2021–2032)
 Figure 62. Single-target MET TKIs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Multi target MET TKIs Market Research Report 2024
Global MET TKIs Market Research Report 2024
Global TKIs for Breast Cancer Market Research Report 2024
Global EGFR TKI for Advanced NSCLC Market Research Report 2024
Global TKI for Chronic Myeloid Leukemia Market Research Report 2024
Global MET Inhibitor Drugs Market Research Report 2025
Global EGFR TKI Market Research Report 2024
Nilotinib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Janus Kinase inhibitors JAKi Market Research Report 2024
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024
Global C MET HGF Inhibitors Market Research Report 2024
Global Radotinib Market Research Report 2024
Multikinase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ponatinib Tablets Market Research Report 2024
Global MEK Inhibitor Market Research Report 2024
Global Leukemia Targeted Therapy Drugs Market Research Report 2024
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
Global ALK Inhibitors Market Research Report 2024
Global Single target Anti VEGF Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions